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Abstract
Background:  The antiestrogen ICI 182,780 has been used successfully as an alternative
experimental model for the study of estrogen action in the rodent adult male reproductive tract.
Although ICI 182,780 causes severe alterations in testicular and efferent ductule morphology and
function, the effects on the expression of estrogen and androgen receptors in the male have not
been shown.
Methods: In the present study, adult male rats were treated with ICI 182,780 for 7 to 150 days,
to evaluate the time-response effects of the treatment on the pattern of ERα, ERβ and AR protein
expression in the efferent ductules. The receptors were localized using immunohistochemistry.
Results: ERα, ERβ and AR have distinct cellular distribution in the testis and efferent ductules.
Staining for ERα is nearly opposite of that for ERβ, as ERα shows an increase in staining intensity
from proximal to distal efferent ductules, whereas ERβ shows the reverse. Androgen receptor
follows that of ERα. ICI 182,780 caused a gradual but dramatic decrease in ERα expression in the
testis and efferent ductules, but no change in ERβ and AR expression.
Conclusions: The differential response of ERα and ERβ proteins to ICI 182,780 indicates that
these receptors are regulated by different mechanisms in the male reproductive tract.
Background
The efferent ductules express significant levels of the two
subtypes of estrogen receptor, ERα and ERβ [1], which can
be co-localized in the epithelial cells of several species [2–
6]. Targeted disruption of the ERα in the mouse (αERKO)
or both ERα and ERβ (αβERKO) caused abnormalities in
the efferent ductules and impaired male fertility [7–12].
This is in contrast with the reproductive tract phenotype
of the ERβ knockout mice (βERKO), which are fertile
[11,13]. These results highlighted the importance of the
efferent ductules and a functional ERα for the male repro-
ductive tract.
Published: 10 October 2003
Reproductive Biology and Endocrinology 2003, 1:75
Received: 05 June 2003
Accepted: 10 October 2003
This article is available from: http://www.RBEj.com/content/1/1/75
© 2003 Oliveira et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all 
media for any purpose, provided this notice is preserved along with the article's original URL.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/75
Page 2 of 12
(page number not for citation purposes)
ERα and ERβ possess remarkable similarities to one
another, but they also possess individual characteristics
that suggest functional differences [14–16]. Structurally,
the rat ERα and ERβ have 95% identity in the DNA bind-
ing domain, but no more than 55% homology in the lig-
and binding domain [14]. As a consequence, different
binding affinity for a variety of estrogenic and antiestro-
genic compounds [17,18] and different transactivation
activity depending on ligand and response element for the
ERα and ERβ has been reported [16,19–22]. Therefore,
different responses of ERα and ERβ to ligands in different
tissues can be expected.
Treatment of rodents with the antiestrogen ICI 182,780
has been shown to be an alternative and efficient experi-
mental model for the study of estrogen action in the male
reproductive tract, bypassing the problems of develop-
mental estrogen receptor absence seen in the transgenic
mice [12,23–26]. ICI 182,780 is a potent steroidal anties-
trogen, which can bind to both ER subtypes [16,17,27],
but the binding patterns for ICI 182,780, as well as for
estradiol, are distinct on both ERα and ERβ [28]. Long-
term treatment with ICI 182,780 promoted adult dysfunc-
tional changes in the rat efferent ductules and culminated
in testicular atrophy and infertility [25] similar to changes
observed in the α ERKO male [8,9]. Changes in efferent
ductules included luminal dilation (up to 200%), gradual
reduction in epithelial height and transient increase in lys-
osomal area and microvilli height in nonciliated cells.
Extending these results, a recent study established the time
course of the events that led to testicular atrophy and
infertility in rats after ICI-treatment and showed that
effects on the efferent ductules preceded the adverse
effects in the testis [26]. Although these studies are the first
to demonstrate that a functional ER is essential for fertility
in the rat and for maintenance of efferent ductules mor-
phology, the molecular effects of ICI 182,780 on the
expression of ER in the male have not been determined.
Given the potential importance of estrogen for the male
reproductive tract function [9,29,30] and the known
effects of the antiestrogen ICI 182,780 on testis and effer-
ent ductules [12,23,25,26], we investigated the mecha-
nism of ICI 182,780 effects, looking for alterations on the
pattern of ERα and ERβ protein expression in the rat effer-
ent ductules. In addition, the expression of androgen
receptors (AR) was also analyzed, given the known
dependence on androgens for male tract function and the
partial overlap of cellular distribution for AR and ERs
[2,31,32]. It is well established that neonatal estrogen
exposure causes alterations in the expression of AR [3,33–
35]; therefore, we hypothesized that ER disruption in the
adult could also alter AR expression in the male. Our
results show that ICI 182,780 causes a dramatic decrease
in ERα expression in the efferent ductules, but no change
in ERβ and AR expression was observed throughout the
study period.
Material and methods
Animals and treatment
Male Sprague-Dawley rats, 30 days old, were purchased
from Harlan Bioproducts (Indianapolis, IN) and housed
in a light (12 h of light, 12 h of darkness) and temperature
(22°C) controlled environment. They were fed with com-
mercial diet (Teklad Chow-Harlan Teklad, Madison, WI)
and provided tap water ad libitum. All animal experi-
ments were approved by the University of Illinois Divi-
sion of Animal Resources and conducted in accordance
with the Guide for the Care and Use of Laboratory Ani-
mals [36].
The rats were treated once per week with subcutaneous
injections of ICI 182,780 (Faslodex – provided by Astra-
Zeneca, Macclesfield, UK), at a dosage of 10 mg/animal in
a volume of 0.2 ml of vehicle. This dosage was found to
be effective for inducing effects on rat efferent ductule
without inducing significant differences on body and sex-
ual gland weights, as well as in plasma testosterone and
LH levels [25,26]. The control group received the same
volume of castor oil. The treatment was initiated when the
rats were 30 days old and the animals were euthanized on
Days 7, 15, 45, 73, 100 or 150 after the beginning of the
treatment.
Immunohistochemistry
ERα, ERβ and AR proteins were localized by immunohis-
tochemistry in testes and efferent ductules of matched
control and ICI 182,780 treated rats (3 animals per
group). The rats were anesthetized (i.p. sodium pentobar-
bital 0.1 ml/100 g BW) and perfused intracardially with
10% neutral buffer formalin (NBF). After fixation, the
efferent ductules were dissected out from the testes and
epididymides. The efferent ductules and fragments of the
testes were embedded in paraffin, sectioned at 5 µm and
mounted on electrostatically charged glass slides.
Antibodies
A mouse monoclonal antibody raised against the full-
length human ERα, the NCL-ER-6F11 (Novocastra Labo-
ratories, Newcastle, UK), was used for immnunolocaliza-
tion of ERα. The Genbank sequence data for the A/B
region of rat and human ERα showed approximately 92%
of similarity and this antibody does not cross-react with
ERβ [37]. For ERβ detection, an affinity purified sheep
polyclonal antibody (S-40) directed against a peptide spe-
cific for the hinge domain (D) of human/rat ERβ was used
[4]. The specificity of the ERα and ERβ antibodies was
confirmed by Western blot analysis and the validation for
use in rat male reproductive tract was previously shown
[4,37]. AR was detected by an affinity purified polyclonalReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/75
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antibody (PG21-29) developed against a peptide corre-
sponding to the first 21 amino acids of the rat/human
androgen receptor [38,39].
Procedure
The immunohistochemical procedure was similar for all
receptors. Tissue sections from treated and control ani-
mals at each time point were run in parallel, and the stain-
ing was performed in three different sets using one animal
of each time point per set to confirm the results. Sections
were dewaxed in xylene, rehydrated through a graded
series of ethanol, washed in distilled water and phosphate
buffer saline (PBS) and then blocked for endogenous per-
oxidase by incubation with 0.6% H2O2 in methanol for 30
min. The sections were subjected to antigen retrieval pro-
cedure by microwave irradiation in 0.01 M sodium citrate
buffer pH 6.0. After washing in PBS, the avidin-biotin
non-specific binding was blocked using a Vector blocking
kit (Vector Laboratories, Burlingame, CA). Additional
washing in PBS was performed before the next 30 min
incubation in 10% normal goat or rabbit serum, for ERα,
AR and ERβ respectively, to prevent nonspecific binding
of the antibodies. The sections were incubated overnight
at 4°C with the respective primary antibody. The dilution
of the antibodies used was 1:500 for ERα and AR, and
1:1000 for ERβ. For negative controls, the sections
received PBS in place of the primary antibody. Prostate
and testis tissue were used for positive control of the ERβ
and AR, respectively. Because the efferent ductules are
known to express high levels of ERα [1], they served as its
own positive control. After washing in PBS, the sections
were exposed for 1 h to a biotinylated secondary antibody
goat anti-mouse (for ERα) (Dako, Carpinteria, CA), rabbit
anti-sheep (for ERβ) (Vector, Burlingame, CA) and goat
anti-rabbit (for AR) (Dako, Carpinteria, CA), all used at
1:100 dilution. After this step the sections were incubated
with the avidin-biotin complex (Vectastain Elite ABC kit –
Vector Laboratories, Burlingame, CA) for 30 min. To visu-
alize the immunoreaction, sections were immersed in
0.05% 3,3' diaminobenzidine containing 0.01% H2O2 in
0.05 M Tris-HCl buffer, pH 7.6. The reaction was moni-
tored microscopically and stopped by immersion in dis-
tilled water, after a brown color staining was visualized in
control sections. Sections were finally dehydrated in etha-
nol, cleared in xylene and mounted. Sections stained for
ERβ and AR were slightly counterstained with Mayer's
hematoxylin before dehydration.
Quantification
Digital images from immunohistochemical staining from
efferent ductules of treated and control animals were cap-
tured. ERα on days 15, 45 and 150, ERβ and AR on day
150 were analyzed. In Adobe Photoshop (San Jose, Cali-
fornia), the images were first adjusted to equalize the
background across all images to a white color. Ten nuclei
with a well-defined edge from three different efferent duc-
tules per animal (3 animals per treatment) were pasted
onto a new image for import into IPLab software (Scana-
lytics, Inc., Fairfax, VA). Then the mean intensity of parti-
cles per nucleus was determined after segmentation to
provide complete nuclear identification. Pixel intensity
means were analyzed first by One-way ANOVA followed
by the Student-Newman-Keuls multiple comparisons test
to detect differences between control and ICI-treatment,
at individual time points. Results are presented as Means
± SEM (Table 2) and significant differences are indicated
by different superscript letters.
Results
The rat testis and efferent ductules expressed ERα and ERβ,
as well as AR, and the antiestrogen ICI 182,780 induced
different alterations in the expression of these receptors
(Table 1). Distinct cellular distribution was observed for
all receptors analyzed. ERα expression was predominately
expressed in the testicular interstitial space (Fig. 1) and the
efferent ductule epithelium (Fig. 2). In contrast, ERβ and
AR were found more widely expressed in the testis (Fig. 1),
rete testis, efferent ductules and initial segment of the
epididymis (Fig. 3 and 4). Longitudinal sections of the
efferent ductules allowed the analysis of labeling intensity
in different regions of the organ (proximal, conus and ter-
minal region) simultaneously. Immunoreactive product
was not observed in the sections when PBS replaced the
primary antibody.
In the testis, ERα was immunodetected in nuclei of Leydig
cells and some peritubular myoid cells (Fig. 1), whereas
the seminiferous epithelium and rete testis were negative
(Fig. 2). The Leydig cells were stained moderately to
weakly positive. The efferent ductule epithelium was
stained intensely positive for ERα (Fig. 2), but the initial
segment of the epididymis was negative (Fig. 2).
In the efferent ductules, ERα was located in both ciliated
and nonciliated cell nuclei. However, staining intensity
did vary throughout the efferent ductules, from proximal
to distal regions. At the proximal end of the ducts, adja-
cent to the rete testis, the ciliated cells showed a more
intense nuclear staining for ERα compared to the noncili-
ated cells (Fig 2E), but the nonciliated cell nuclear stain-
ing reached its strongest intensity in approximately the
middle of the proximal region and staining intensity con-
tinued into the conus and common efferent ductules.
Another interesting difference in staining in the proximal
efferent ductule region was the presence of cytoplasmic
staining for ERα in the ciliated cells, which contrasted
with the strictly nuclear staining in the nonciliated cells
(Fig. 2A, 2E, 2I). A slight cytoplasmic staining was also
observed in nonciliated cells in the conus and terminal
regions (Fig. 2B, 2F, 2J). ICI 182,780 caused ERα down-Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/75
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regulation in efferent ductules at all time points analyzed
(Fig. 2) and also in the testis (Fig 1). At day 7 there was a
slight decrease in the ERα expression when control and
ICI-treated animals were compared. Pixel analysis of the
immunohistochemical staining revealed significant
decreases (P < 0.05) in intensity on days 45 and 150 for
ERα (Table 2). On days 100 and 150 (Fig. 2), ERα down-
regulation was nearly complete, reaching levels nearly
undetectable. Down-regulation of ERα was more pro-
nounced in the proximal region of the efferent ductules
(Fig. 2).
Positive staining for ERβ was detected in the nuclei of the
rete testis, efferent ductules and initial segment epithelial
cells, as well as endothelial and some stromal cells (Fig.
3). An intermittent ERβ positive staining was seen in
smooth muscle cells surrounding the efferent ductules.
The staining was weaker in the efferent ductule epithelium
compared to that of the initial segment of the epididymis.
There was a gradient of epithelial ERβ immunoexpression,
with stronger staining at the proximal ducts than the distal
region of the efferent ductules. In the testis, positive stain-
ing was present in the Sertoli and germ cells (Fig. 1). Ser-
toli cells were the most intensely stained for ERβ,
independent of the stage in the cycle of the seminiferous
epithelium. A slight staining of Leydig cells was occasion-
ally found. In the ICI-treated rats, no detectable change in
ERβ expression pattern was found in the testis, efferent
ductules or initial segment compared to controls at all
time points investigated (Fig. 1 and 3). There was no sta-
tistical difference in mean pixel intensities for ERβ
between control and treatment nuclei (Table 2).
Immunoreaction for AR was detected in the nuclei of cili-
ated and nonciliated cells of the efferent ductules, in addi-
tion to peritubular and some connective tissue cells;
including smooth muscle cells of the vascular walls (Fig.
4). The peritubular cells were strongly stained throughout
the efferent ductules, but a gradient of AR expression was
observed for the efferent ductule epithelium. AR staining
in the epithelium increased from the proximal to distal
region. Rete testis and initial segment epithelial cells were
strongly positive for AR in both epithelial and stromal
cells. Staining of the initial segment epithelium was
Table 1: Comparison of immunohistochemical staining for ERα, ERβ and AR in the testis, efferent ductules and initial segment of the 
epididymis of control and ICI 182,780 treated rats, as observed after 150 days of treatment.
SC GC LC PC ED-P ED-D IS
ERα
Con - - ++ -/+ +++ ++++ -
I C I -----+ -
ERβ
Con +++ + + -/+ ++++ +++ ++++
ICI +++ + + -/+ ++++ +++ ++++
AR
Con +++/+ - +++ +++ ++ +++ ++++
ICI +++/+ - +++ +++ ++ +++ ++++
SC = Sertoli cells; GC = germ cells; LC = Leydig cells; PC = peritubular myoid cells; ED-P = proximal efferent ductules; ED-D = distal efferent 
ductules; IS = initial segment of the epididymis; Con = control; ICI = ICI 182,780 treated; - = negative; + = weak stain; ++ = moderate stain; +++ = 
strong stain; ++++ = strongest stain; -/+ = intermittent stain; +++/+ = variable intensity of stain depending on the seminiferous tubules stage.
Table 2: Quantification of immunohistochemistry for ERα, ERβ and AR in the efferent ductules of control and ICI 182,780 treated rats.
Day post treatment
15b 45b 150b
Receptor Control ICI Control ICI Control ICI
ERα 102.7 ± 7.0a 82.3 ± 2.6a 115.9 ± 3.8a, b 78.8 ± 11.9a, c 131.7 ± 11.1a, b 56.3 ± 3.8d
ERβ 117.5 ± 10.7a 131.7 ± 9.1a
AR 126.3 ± 6.4a 130.6 ± 9.7a
Pixel intensity per unit area of the nucleus was determined and means ± SEM are reported. Significant differences are indicated by different 
superscripts (P < 0.05) based on ANOVA one way-analysis of variance.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/75
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stronger than that in efferent ductules. In the testis,
nuclear AR-positive staining was detected in Leydig, Ser-
toli, peritubular myoid cells and vases smooth muscle
cells (Fig. 1). In the Sertoli cells the intensity of AR expres-
sion varied depending upon the stage of the cycle of the
seminiferous epithelium. ICI 182,780 failed to alter the
Effects of ICI 182, 780 in the expression of ERα, ERβ and AR in the rat testis Figure 1
Effects of ICI 182, 780 in the expression of ERα, ERβ and AR in the rat testis. (A) Leydig cells (L) and some myoid cells (arrow) 
are positive for ERα in the control rats. (B) ERα immunostaining is not detected after 100 days of ICI treatment. (C) ERβ was 
strongly expressed in the Sertoli cells (S) and slightly expressed in the germ cells in the seminiferous epithelium (E) and inter-
stitial cells (L). (D) The ERβ expression was unaffected by the ICI treatment, as shown at day 45. (E) AR expression was found 
in the Sertoli cells (S), Leydig cells (L) and peritubular myoid cells (arrow). (F) There were no detectable effects on the AR 
expression after ICI treatment, as shown at day 45. Bar in A = 50 µm.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/75
Page 6 of 12
(page number not for citation purposes)
pattern of expression of AR in the testis, rete testis, efferent
ductules and initial segment of the epididymis compared
with the respective controls at any time point studied (Fig.
1 and 4). There was no statistical difference in mean pixel
intensities for AR between control and treatment nuclei
(Table 2).
Discussion
ICI 182,780 treatment resulted in a dramatic decrease in
ERα in the rat efferent ductules, but no detectable changes
were found for ERβ and AR. This study further demon-
strated that ERα and ERβ respond differently in the male
genital tract to this antiestrogen treatment. In addition,
the present findings extend earlier data showing that these
nuclear steroid receptors are expressed in the efferent duc-
tules. However, the efferent ductule epithelium from the
proximal to the distal region showed differential staining.
ERα, ERβ and AR cellular distributions found in the adult
rat efferent ductules and testis were consistent with those
previously reported [3,32,37,40–48]. However, the
present study found increasing expression of ERα and AR
from the proximal to the distal region of the efferent duc-
tules, in contrast to prior studies. The significance of this
differential staining of steroid receptors along the efferent
ductule epithelium is not known. However, we have
Effects of ICI 182, 780 on the expression of ERα in the rat efferent ductules Figure 2
Effects of ICI 182, 780 on the expression of ERα in the rat efferent ductules. In the control rats (A, B, E, F, I, J), ERα was 
expressed in the nuclei of ciliated (c) and nonciliated cells in the efferent ductules epithelium. Cytoplasmic staining was 
observed in the ciliated cells (c) at the proximal tubules (A, E, I and insert in E) and in both cell types in the distal tubules 
(EDd) (B, F, J). After 7 days of ICI treatment (C, D) a slight decrease in ERα was observed along the efferent ductules. On 
day 45 (G, H), ERα expression was greatly decreased with the treatment. On day 150 (K, L), the ERα expression was further 
decreased. Insert in A represents the negative control. Bar in A = 50 µm.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/75
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Effects of ICI 182, 780 on the expression of ERβ in the rat efferent ductules Figure 3
Effects of ICI 182, 780 on the expression of ERβ in the rat efferent ductules. In the control rats (A, B, E, F), ERβ was 
expressed in the nuclei of the efferent ductules epithelial and some stromal cells (*). An intermittent staining was also detected 
in the peritubular cells (arrow); (c) ciliated cells. Insert in A represents the negative control. The ERβ staining was stronger in 
the efferent ductules proximal tubules and initial segment of the epididymis when compared to the efferent ductules distal 
tubules. There were no detectable changes in the efferent ductules ERβ expression after ICI treatment (C, D, G, H). EP = 
epididymis. Bar in A = 50 µm.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/75
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Effects of ICI 182, 780 on the expression of AR in the rat efferent ductules Figure 4
Effects of ICI 182, 780 on the expression of AR in the rat efferent ductules. In the control rats (A, B, E, F), AR expression was 
found in the nuclei of the efferent ductules epithelial, peritubular (arrow) and some stromal cells (*). The AR staining in the 
proximal tubules was weaker than that on distal tubules and initial segment of the epididymis (EP). (c) Ciliated cells. Insert in A 
represents the negative control. After ICI treatment (C, D, G, H), the AR expression was apparently unchanged along the 
efferent ductules. Bar in A = 50 µm.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/75
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previously observed an expression pattern for the sodium/
hydrogen exchanger (NHE3) protein that is similar to the
ERα and AR staining [26]. It is noteworthy that an oppo-
site pattern of staining was observed for ERβ. NHE3
appears to be one of the most important molecules in
mediating fluid reabsorption in the efferent ductules
[12,49]. NHE3 expression in the efferent ductules has
been shown to be regulated by estrogen at the protein and
mRNA levels [12,26], therefore differential expression of
NHE3 and ERα is consistent with these prior physiologi-
cal studies.
The immunohistochemical demonstration of cytoplasmic
staining for ERα in the ciliated cells of the efferent duc-
tules was an intriguing observation. Although previous
studies [1,2,37] did not discuss this difference, a reexami-
nation of figures published by Hess et al (1997b) and Nie
et al (2002) showed cytoplasmic staining in the ciliated
cells from the rat and cat, respectively. ERα cytoplasmic
distribution has also been described in other tissues
[50,51]. It was shown that different accessibility of the ER
to the reagents depending upon the functional activity of
the estradiol-controlled cells could interfere with subcel-
lular immunolocalization of the receptor [50,52]. In
agreement with this finding, ERα and ERβ were more fre-
quently localized to the cytoplasm of resting uterine cells
[51] and human breast cells [45]. In addition, species dif-
ferences in the ERα staining of efferent ductules epithelial
cells has also been noted, with goat and primate ciliated
cells being negative [37,53]. In this sense, one possibility
is that ciliated cells of the efferent ductules have a lower
requirement for estradiol-induced activity than do the
nonciliated cells. This would be consistent with the
known function of efferent ductules, reabsorption of 96%
of the luminal fluid [54], which is more dependent on the
nonciliated cells than the ciliated cells.
ICI 182,780 decreased the expression of ERα in both testis
and efferent ductules, but ERβ and AR were not altered by
the treatment. The down-regulation of ERα protein fol-
lowing ICI treatment has already been described in other
tissues, but most of the studies were performed on female
reproductive organs or cell cultures [55–58]. The down-
regulation of ERα protein by ICI is thought to be due to a
change in the ERα conformation, which leads to a rapid
loss of the receptor [55,59,60]. At first, lysosomes were
thought to serve as the organelle that degrades ERα after
estradiol or antiestrogen treatment [51,61]. However,
recent in vitro experiments provided evidence that the
ERα degradation occurs through the 26S proteasome
pathway, but not lysosomes [62–64]. In the present study,
the reduction in ERα nuclear staining after ICI 182,780
treatment was not followed by an increase in the cytoplas-
mic staining of the nonciliated cells, as described for other
cell types in vitro [57,65,66]. However, a transient
increase of nearly 170% in lysosomal area in ICI-treated
rat nonciliated cells was recently described [25,26]. Thus,
further study of proteasomal and lysosomal degradation
of steroid receptors in the male is warranted.
The fact that ERα, but not ERβ, was down-regulated by ICI
182,780 in the rat efferent ductules, suggests that the ER
subtypes are regulated in a different manner in this tissue.
In agreement with our results showing approximately
60% decrease in the ERα level after ICI-treatment, other
have shown that ICI 182,780 is similar to estradiol in its
ability to decrease its receptor approximately 50%
[62,64]. This effect differs from that of the partial ER
antagonist Tamoxifen, which was incapable of down-reg-
ulating ERα, suggesting the existence of ligand-specific
regulation of ERα [64]. These data may also be helpful in
the development of an appropriate antiestrogenic chemi-
cal that targets ERα function selectively in efferent duc-
tules of the male reproductive tract, permitting the
development of a novel male contraceptive.
Differential regulation of ERα and ERβ should not be sur-
prising, because regardless of their structural homology
[14], several functional differences between both ER sub-
types have been found [19,20,22,67]. In addition, there
are now reported several differential effects of ICI 182,780
on ERα and ERβ [16,28,68–71]. In support of our results,
neonatal diethylstilbestrol (DES) treatment has also
shown differential changes in ERα, but not ERβ immu-
noexpression in the male rat reproductive tract [3]. In con-
trast to the data presented here, which suggests that ERα
does not have a direct regulatory effect on AR expression
in testis and efferent ductules, in the prostate gland AR has
been shown to be down regulated by estrogens in a lobe-
specific manner during development [38,72]. Although
the prostate effect appears to be mediated through ERα, as
AR expression in the α ERKO male is normal even follow-
ing DES treatment [72], ERβ cannot be ignored because
DES treatment of the β ERKO males during the perinatal
period also induced a lobe-dependent decreased expres-
sion of AR [72].
ERβ expression in the male reproductive system is rather
extensive [1,14,30,43,44], but targeted disruption of ERβ
has not resulted in any significant pathogenesis in the
male [11,13], and estrogen and antiestrogen treatment
has not caused effects on the expression of ERβ. It has
been proposed that ERβ modulates ERα effects in the
uterus [13,73,74] and cervix [75], but currently, the role of
ERβ in the male tract remains uncertain. A recent study
using α ERKO and ICI-treated normal and α ERKO mice
[24] attributed to ERβ a role in mediating the estrogen
down-regulation of several ion transporter (CFTR, DRA
and NA/K ATPase). However, they did not account for theReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/75
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maintenance of ERβ expression and possibly functional
activity in α ERKO and after ICI treatment.
Conclusions
The results obtained by treating adult male rats with the
pure antiestrogen ICI 182,780 show that ERα and ERβ
expression are regulated by different mechanisms in the
testis and epididymis. ICI 182,780 binds to both receptors
but only causes the disappearance of the ERα protein. The
expression of AR was unaffected by the antiestrogen in tes-
tis and epididymis.
Authors' contributions
CAO helped to design the study and carried out the exper-
iments and wrote the first draft of the manuscript. RN
assisted with the immunohistochemistry. KC provided
laboratory assistance. LRF helped in the design of the
study and served as advisor to CAO. GSP provided the AR
antibody and consultation in its use. PTKS provided the
ERβ antibody and consultation in its use. RAH served as
PI on this project and helped with study design. All
authors read and approved the final manuscript.
Acknowledgments
We are grateful to the generous supply of ICI 182,780 provided by Astra-
Zeneca, Macclesfield, UK. This research was supported in part by NIH 
grant number HD35126 (RAH) and CONRAD.
References
1. Hess RA, Gist DH, Bunick D, Lubahn DB, Farrell A, Bahr J, Cooke PS
and Greene GL: Estrogen receptor (a & b) expression in the
excurrent ducts of the adult male rat reproductive tract. J
Androl 1997, 18:602-611.
2. Nie R, Zhou Q, Jassim E, Saunders PT and Hess RA: Differential
expression of estrogen receptors a and b in the reproductive
tracts of adult male dogs and cats.  Biol Reprod 2002,
66:1161-1168.
3. Atanassova N, McKinnell C, Williams K, Turner KJ, Fisher JS, Saun-
ders PT, Millar MR and Sharpe RM: Age-, cell- and region-specific
immunoexpression of estrogen receptor alpha (but not
estrogen receptor beta) during postnatal development of
the epididymis and vas deferens of the rat and disruption of
this pattern by neonatal treatment with diethylstilbestrol.
Endocrinology 2001, 142:874-886.
4. Williams K, Saunders PTK, Atanassova N, Fisher JS, Turner KJ, Millar
MR, McKinnell C and Sharpe RM: Induction of progesterone
receptor immunoexpression in stromal tissue throughout
the male reproductive tract after neonatal oestrogen treat-
ment of rats. Mol Cell Endocrinol 2000, 164:117-131.
5. Saunders PT, Sharpe RM, Williams K, Macpherson S, Urquart H,
Irvine DS and Millar MR: Differential expression of oestrogen
receptor alpha and beta proteins in the testes and male
reproductive system of human and non-human primates. Mol
Hum Reprod 2001, 7:227-236.
6. Zhou Q, Nie R, Prins GS, Saunders PT, Katzenellenbogen BS and Hess
RA: Localization of androgen and estrogen receptors in adult
male mouse reproductive tract. J Androl 2002, 23:870-881.
7. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS and Smithies
O: Alteration of reproductive function but not prenatal sex-
ual development after insertional disruption of the mouse
estrogen receptor gene.  Proc Natl Acad Sci USA 1993,
90:11162-11166.
8. Eddy EM, Washburn TF, Bunch DO, Goulding EH, Gladen BC, Lubahn
DB and Korach KS: Targeted disruption of the estrogen recep-
tor gene in male mice causes alteration of spermatogenesis
and infertility. Endocrinol 1996, 137:4796-4805.
9. Hess RA, Bunick D, Lee KH, Bahr J, Taylor JA, Korach KS and Lubahn
DB: A role for oestrogens in the male reproductive system.
Nature 1997, 390:509-512.
10. Couse JF and Korach KS: Exploring the role of sex steroids
through studies of receptor deficient mice [see comments].
J Mol Med 1998, 76:497-511.
11. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P and Mark
M:  E f f e c t  o f  s i n g l e  a n d  c o m p ound knockouts of estrogen
receptors a (ER a) and b (ER b) on mouse reproductive
phenotypes. Development 2000, 127:4277-4291.
12. Zhou Q, Clarke L, Nie R, Carnes K, Lai LW, Lien YH, Verkman A,
Lubahn D, Fisher JS, Katzenellenbogen BS and Hess RA: Estrogen
action and male fertility: Roles of the sodium/hydrogen
exchanger-3 and fluid reabsorption in reproductive tract
function. Proc Natl Acad Sci U S A 2001, 98:14132-14137.
13. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar
M, Korach KS, Gustafsson JA and Smithies O: Generation and
reproductive phenotypes of mice lacking estrogen receptor
beta. Proc Natl Acad Sci USA 1998, 95:15677-15682.
14. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S and Gustafsson JA:
Cloning of a novel receptor expressed in rat prostate and
ovary. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:5925-5930.
15. Mosselman S, Polman J and Dijkema R: ER beta: identification and
characterization of a novel human estrogen receptor. FEBS
Lett 1996, 392:49-53.
16. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA,
Labrie F and Giguere V: Cloning, chromosomal localization, and
functional analysis of the murine estrogen receptor beta. Mol
Endocrinol 1997, 11:353-365.
17. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S
and Gustafsson JA: Comparison of the ligand binding specificity
and transcript tissue distribution of estrogen receptors alpha
and beta. Endocrinol 1997, 138:863-870.
18. Harris HA, Bapat AR, Gonder DS and Frail DE: The ligand binding
profiles of estrogen receptors a and b are species dependent.
Steroids 2002, 67:379-384.
19. Paech K, Webb P, Kuiper Ggjm, Nilsson S, Gustafsson J, angst, Kush-
ner PJ and Scanlan TS: Differential ligand activation of estrogen
receptors ERalpha and ERbeta at AP1 sites.  Science 1997,
277:1508-1510.
20. Pennie WD, Aldridge TC and Brooks AN: Differential activation
by xenoestrogens of ERa and ERb when linked to different
response elements. J Endocrinol 1998, 158:R11-R14.
21. Loven MA, Wood JR and Nardulli AM: Interaction of estrogen
receptors alpha and beta with estrogen response elements.
Mol Cell Endocrinol 2001, 181:151-163.
22. Schultz JR, Loven MA, Melvin VM, Edwards DP and Nardulli AM: Dif-
ferential modulation of DNA conformation by estrogen
receptors alpha and beta. J Biol Chem 2002, 277:8702-8707.
23. Lee KH, Hess RA, Bahr JM, Lubahn DB, Taylor J and Bunick D: Estro-
gen receptor alpha has a functional role in the mouse rete
testis and efferent ductules. Biol Reprod 2000, 63:1873-1880.
24. Lee KH, Finnigan-Bunick C, Bahr J and Bunick D: Estrogen Regula-
tion of Ion Transporter Messenger RNA Levels in Mouse
Efferent Ductules Are Mediated Differentially Through
Estrogen Receptor (ER) alpha and ERbeta. Biol Reprod 2001,
65:1534-1541.
25. Oliveira CA, Carnes K, Franca LR and Hess RA: Infertility and tes-
ticular atrophy in the antiestrogen-treated adult male rat.
Biol Reprod 2001, 65:913-920.
26. Oliveira CA, Zhou Q, Carnes K, Nie R, Kuehl DE, Jackson GL, Franca
LR, Nakai M and Hess RA: ER Function in the Adult Male Rat:
Short- and Long-Term Effects of the Antiestrogen ICI
182,780 on the Testis and Efferent Ductules, without
Changes in Testosterone. Endocrinology 2002, 143:2399-2409.
27. Wakeling AE: Similarities and distinctions in the mode of
action of different classes of antioestrogens. Endocr Relat Cancer
2000, 7:17-28.
28. Paige LA, Christensen DJ, Gron H, Norris JD, Gottlin EB, Padilla KM,
Chang CY, Ballas LM, Hamilton PT, McDonnell DP and Fowlkes DM:
Estrogen receptor (ER) modulators each induce distinct
conformational changes in ER alpha and ER beta. Proc Natl
Acad Sci U S A 1999, 96:3999-4004.
29. Hess RA, Bunick D and Bahr J: Oestrogen, its receptors and func-
tion in the male reproductive tract - a review.  Mol Cell
Endocrinol 2001, 178:29-38.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/75
Page 11 of 12
(page number not for citation purposes)
30. Hess RA: Estrogen in the adult male reproductive tract: A
review. Reprod Biol Endocrinol 2003, 1:52-65.
31. Sar M and Welsch F: Oestrogen receptor alpha and beta in rat
prostate and epididymis. Andrologia 2000, 32:295-301.
32. Turner KJ, Morley M, MacPherson S, Millar MR, Wilson JA, Sharpe RM
and Saunders PT: Modulation of gene expression by androgen
and oestrogens in the testis and prostate of the adult rat fol-
lowing androgen withdrawal. Mol Cell Endocrinol 2001, 178:73-87.
33. Newbold RR, Bullock BC and McLachlan JA: Mullerian remnants
of male mice exposed prenatally to diethylstilbestrol. Teratog
Carcinog Mutagen 1987, 7:377-389.
34. Tena-Sempere M, Navarro J, Pinilla L, Gonzalez LC, Huhtaniemi I and
Aguilar E: Neonatal exposure to estrogen differentially alters
estrogen receptor alpha and beta mRNA expression in rat
testis during postnatal development.  J Endocrinol 2000,
165:345-357.
35. Prins GS, Birch L and Greene GL: Androgen receptor localiza-
tion in different cell types of the adult rat prostate. Endocrinol
1991, 129:3187-3199.
36. NRC:  Guide for the care and use of laboratory animals.
National Research Council  Washington, D.C., National Academy Press;
1996:125. 
37. Fisher JS, Millar MR, Majdic G, Saunders PT, Fraser HM and Sharpe
RM: Immunolocalisation of oestrogen receptor-alpha within
the testis and excurrent ducts of the rat and marmoset mon-
key from perinatal life to adulthood.  J Endocrinol 1997,
153:485-495.
38. Prins GS: Neonatal estrogen exposure induces lobe-specific
alterations in adult rat prostate androgen receptor
expression. Endocrinology 1992, 130:3703-3714.
39. Prins GS and Birch L: The developmental pattern of androgen
receptor expression in rat prostate lobes is altered after
neonatal exposure to estrogen.  Endocrinology 1995,
136:1303-1314.
40. Cooke PS, Young P, Hess RA and Cunha GR: Estrogen receptor
expression in developing epididymis, efferent ductules, and
other male reproductive organs.  Endocrinology 1991,
128:2874-2879.
41. Roselli CE, West NB and Brenner RM: Androgen receptor and 5
alpha-reductase activity in the ductuli efferentes and epidi-
dymis of adult rhesus macaques. Biol Reprod 1991, 44:739-745.
42. Zhu LJ, Hardy MP, Inigo IV, Huhtaniemi I, Bardin CW and Moo-Young
AJ: Effects of androgen on androgen receptor expression in
rat testicular and epididymal cells: a quantitative immuno-
histochemical study. Biol Reprod 2000, 63:368-376.
43. Saunders PT, Fisher JS, Sharpe RM and Millar MR: Expression of
oestrogen receptor beta (ER beta) occurs in multiple cell
types, including some germ cells, in the rat testis. J Endocrinol
1998, 156:R13-7.
44. van Pelt AM, de Rooij DG, van der Burg B, van der Saag PT, Gustafs-
son JA and Kuiper GG: Ontogeny of estrogen receptor-beta
expression in rat testis. Endocrinology 1999, 140:478-483.
45. Taylor AH and Al-Azzawi F: Immunolocalisation of oestrogen
receptor beta in human tissues.  J Mol Endocrinol 2000,
24:145-155.
46. Sar M, Lubahn DB, French FS and Wilson EM: Immunohistochem-
ical localization of the androgen receptor in rat and human
tissues. Endocrinol 1990, 127:3180-3186.
47. Pelletier G: Localization of androgen and estrogen receptors
in rat and primate tissues. Histol Histopathol 2000, 15:1261-1270.
48. Suarez-Quian CA, Martinez-Garcia F, Nistal M and Regadera J:
Androgen receptor distribution in adult human testis. J Clin
Endocrinol Metab 1999, 84:350-358.
49. Hansen LA, Clulow J and Jones RC: The role of Na+-H+ exchange
in fluid and solute transport in the rat efferent ducts. Exp
Physiol 1999, 84:521-527.
50. Sierralta WD, Bonig I and Thole HH: Immunogold labeling of
estradiol receptor in MCF7 cells.  Cell Tissue Res 1995,
279:445-452.
51. Qualmann B, Kessels MM, Thole HH and Sierralta WD: A hormone
pulse induces transient changes in the subcellular distribu-
tion and leads to a lysosomal accumulation of the estradiol
receptor alpha in target tissues. Eur J Cell Biol 2000, 79:383-393.
52. Sierralta WD and Thole HH: Retrieval of estradiol receptor in
paraffin sections of resting porcine uteri by microwave treat-
ment. Immunostaining patterns obtained with different pri-
mary antibodies. Histochem Cell Biol 1996, 105:357-363.
53. Goyal HO, Bartol FF, Wiley AA, Khalil MK, Chiu J and Vig MM:
Immunolocalization of androgen receptor and estrogen
receptor in the developing testis and excurrent ducts of
goats. Anat Rec 1997, 249:54-62.
54. Clulow J, Jones RC, Hansen LA and Man SY: Fluid and electrolyte
reabsorption in the ductuli efferentes testis. J Reprod Fertil Suppl
1998, 53:1-14.
55. Wijayaratne AL, Nagel SC, Paige LA, Christensen DJ, Norris JD,
Fowlkes DM and McDonnell DP: Comparative analyses of mech-
anistic differences among antiestrogens.  Endocrinology 1999,
140:5828-5840.
56. Bentrem D, Dardes R, Liu H, MacGregor-Schafer J, Zapf J and Jordan
V:  Molecular mechanism of action at estrogen receptor
alpha of a new clinically relevant antiestrogen (GW7604)
related to tamoxifen. Endocrinology 2001, 142:838-846.
57. Stenoien DL, Patel K, Mancini MG, Dutertre M, Smith CL, O'Malley
BW and Mancini MA: FRAP reveals that mobility of oestrogen
receptor-alpha is ligand- and proteasome-dependent. Nat Cell
Biol 2001, 3:15-23.
58. Wijayaratne AL and McDonnell DP: The human estrogen recep-
tor-alpha is a ubiquitinated protein whose stability is affected
differentially by agonists, antagonists, and selective estrogen
receptor modulators. J Biol Chem 2001, 276:35684-35692.
59. Gibson MK, Nemmers LA, Beckman W. C., Jr., Davis VL, Curtis SW
and Korach KS: The mechanism of ICI 164,384 antiestrogenic-
ity involves rapid loss of estrogen receptor in uterine tissue.
Endocrinology 1991, 129:2000-2010.
60. Dauvois S, Danielian PS, White R and Parker MG: Antiestrogen ICI
164,384 reduces cellular estrogen receptor content by
increasing its turnover.  Proc Natl Acad Sci U S A 1992,
89:4037-4041.
61. Borras M, Laios I, el Khissiin A, Seo HS, Lempereur F, Legros N and
Leclercq G: Estrogenic and antiestrogenic regulation of the
half-life of covalently labeled estrogen receptor in MCF-7
breast cancer cells. J Steroid Biochem Mol Biol 1996, 57:203-213.
62. Alarid ET, Bakopoulos N and Solodin N: Proteasome-mediated
proteolysis of estrogen receptor: a novel component in
autologous down-regulation. Mol Endocrinol 1999, 13:1522-1534.
63. Lonard DM, Nawaz Z, Smith CL and O'Malley BW: The 26S pro-
teasome is required for estrogen receptor-alpha and coacti-
vator turnover and for efficient estrogen receptor-alpha
transactivation. Mol Cell 2000, 5:939-948.
64. Preisler-Mashek MT, Solodin N, Stark BL, Tyriver MK and Alarid ET:
Ligand-specific regulation of proteasome-mediated proteol-
ysis of estrogen receptor-alpha. Am J Physiol Endocrinol Metab
2002, 282:E891-8.
65. Dauvois S, White R and Parker MG: The antiestrogen ICI 182780
disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell
Sci 1993, 106:1377-1388.
66. Htun H, Holth LT, Walker D, Davie JR and Hager GL: Direct visu-
alization of the human estrogen receptor alpha reveals a
role for ligand in the nuclear distribution of the receptor. Mol
Biol Cell 1999, 10:471-486.
67. Fournier B, Gutzwiller S, Dittmar T, Matthias G, Steenbergh P and
Matthias P: Estrogen receptor (ER)-alpha, but not ER-beta,
mediates regulation of the insulin-like growth factor I gene
by antiestrogens. J Biol Chem 2001, 276:35444-35449.
68. Pace P, Taylor J, Suntharalingam S, Coombes RC and Ali S: Human
estrogen receptor beta binds DNA in a manner similar to
and dimerizes with estrogen receptor alpha. J Biol Chem 1997,
272:25832-25838.
69. Van Den Bemd GJ, Kuiper GG, Pols HA and Van Leeuwen JP: Dis-
tinct Effects on the Conformation of Estrogen Receptor
alpha and beta by Both the Antiestrogens ICI 164,384 and
ICI 182,780 Leading to Opposite Effects on Receptor
Stability. Biochem Biophys Res Commun 1999, 261:1-5.
70. Pike AC, Brzozowski AM, Walton J, Hubbard RE, Thorsell A, Li Y,
Gustafsson J and Carlquist M: Structural Insights into the Mode
of Action of a Pure Antiestrogen.  Structure (Camb) 2001,
9:145-153.
71. Wade JB, Welling PA, Donowitz M, Shenolikar S and Weinman EJ:
Differential renal distribution of NHERF isoforms and their
colocalization with NHE3, ezrin, and ROMK. Am J Physiol Cell
Physiol 2001, 280:C192-8.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/75
Page 12 of 12
(page number not for citation purposes)
72. Prins GS, Birch L, Couse JF, Choi I, Katzenellenbogen B and Korach
KS: Estrogen imprinting of the developing prostate gland is
mediated through stromal estrogen receptor alpha: studies
with alphaERKO and betaERKO mice.  Cancer Res 2001,
61:6089-6097.
73. Hall JM and McDonnell DP: The estrogen receptor beta-isoform
(ERbeta) of the human estrogen receptor modulates ERal-
pha transcriptional activity and is a key regulator of the cel-
lular response to estrogens and antiestrogens. Endocrinology
1999, 140:5566-5578.
74. Weihua Z, Saji S, Makinen S, Cheng G, Jensen EV, Warner M and Gus-
tafsson JA: Estrogen receptor (ER) beta, a modulator of ERal-
pha in the uterus. Proc Natl Acad Sci U S A 2000, 97:5936-5941.
75. Gorodeski GI and Pal D: Involvement of estrogen receptors
alpha and beta in the regulation of cervical permeability. Am
J Physiol Cell Physiol 2000, 278:C689-96.